4
Changes in Ownership
Processa Pharmaceuticals, Inc. Filed Acc 0000897069-26-001558
Options or other derivatives
- Chief Financial Officer acquired 11,883 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| SKIBSTED RUSSELL Chief Financial Officer | 2026-07-26 | Grant or award · Restricted Stock Units | +11,883 | 17,323 | D | ||
Loading xslF345X06/form4.xml…